AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05353231 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attention Feedback Awareness and Control Training (A-FACT)
Description: A-FACT is designed to promote meta-awareness of moment-to-moment biased internal attention allocation (e.g. toward negative thoughts) and thereby internal attentional control.~Participants will be instructed that they will complete a task designed to reduce their attentional bias to some thoughts. Following a fixation que, the auditory neutral or negative simulated thought stimulus is delivered, and 500ms prior to termination of the auditory stimulus, a visual stimulus is presented until participants categorize the visual stimulus as greater than or smaller than 5 objects. Latency to disengage attention from each thought stimuli, at the trial-level, is repeatedly measured, and after each negative thought stimulus, trial-level feedback on the latency to disengage is delivered back to participants through a visual scale representing their attentional bias. Participants will complete approximately 100 trials in total wherein randomly 1 or 2 neutral trials follow each negative trial.
Study NCT05353231 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindful Disengagement from Thoughts Training (MDTT)
Description: MDTT is designed to promote meta-awareness of moment-to-moment biased internal attention allocation (e.g. toward negative thoughts) and thereby internal attentional control. Participants will be instructed that they will complete a task designed to reduce their attentional bias to some thoughts. Participants will first learn and practice a focused attention on the breath meditation. Then, participants will practice pressing a button each time they notice an inhalation or exhalation during the focused attention meditation. Next, during the meditation, participants will be presented the auditory neutral or negative simulated thought stimuli and will train internal attentional control by repeatedly disengaging their attention from these stimuli and back to their breath MDTT will thus entail 80 trials (40 negative, 40 neutral, ITI ≈ 10sec) during the focused attention on the breath meditation.
Study NCT05353231 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo-Control
Description: The condition is designed as a placebo control for the Attention Feedback Awareness and Control Training (A-FACT) training condition. Participants will be instructed that they will complete a task designed to reduce their attentional bias to some thoughts. Rather than the quantity categorization task with trial-level feedback, participants only engage in the quantity categorization task. The task is identical in all other ways to the A-FACT condition. Participants will complete approximately 100 trials in total wherein randomly 1 or 2 neutral trials follow each negative trial.
Study NCT04728581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Description: Use of 3.75mg mirtazapine before lights-out during first 2 weeks after TKA surgery. With insufficient effect on sleep, patients are allowed to increase medication to 7.5mg mirtazapine.
Study NCT05221112 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: diagonal pattern training
Description: patients will receive proprioceptive neuromuscular facilitation technique's chopping and lifting pattern to create 10 movements.
Study NCT05221112 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: single plane training
Description: patients will receive single plane training of proprioceptive neuromuscular facilitation in control group
Study NCT05492760 — intervention group
Intervention type: DEVICE
Intervention: cryoballoon ablation
Description: Patients with AF will accept cryoballoon ablation.
Study NCT05801055 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evaluation of gastric visibility following the combination drink of N-acetyle cysteine and simethocone
Description: The combination drink containing N-acetyl cysteine and simethicone help to disperse bubbles and mucus present in the stomach. During routine upper gastrointestinal endoscopy mucus and bubbles sometimes may hinder mucosal visibility, so small submucosal lesions, ulcers, erosions, and even flat pre-malignant lesions can be missed during endoscopy. The Japanese guidelines also recommend the use of this combination drink to detect early gastric cancers. So we plan to evaluate the role of this drink in improving gastric mucosal visibility in patients undergoing upper gastrointestinal endoscopy.
Study NCT05045677 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: digital DBT skills intervention
Description: The digital intervention consists of 6 modules that will be delivered over 6 to 10 days. The modules cover mindfulness skills, emotion regulation skills and distress tolerance skills.
Study NCT05045677 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard Care
Description: Standard inpatient care includes a multi-disciplinary team approach including daily psychiatric review, medication management and in-person psychosocial interventions (social work, nursing).
Study NCT05045677 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: Standard inpatient care includes a multi-disciplinary team approach including daily psychiatric review, medication management and in-person psychosocial interventions (social work, nursing).
Study NCT04265859 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Training
Description: The CBT-based regulation training involves using a cognitive strategy that instructs participants to reappraise situations in positive or less negative ways.
Study NCT04265859 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive Behavioral Training
Description: The CBT-based regulation training involves using a cognitive strategy that instructs participants to reappraise situations in positive or less negative ways.
Study NCT04265859 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness
Description: The MBT-based regulation training involves using a mindfulness strategy that instructs participants to notice and accept their feelings without judgment or intent to act upon them.
Study NCT06386341 — intervention group
Intervention type: PROCEDURE
Intervention: Maxillomandibular Advancement Surgery
Description: Surgery where the upper and lower jaw are repositioned.
Study NCT04265859 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Mindfulness
Description: The MBT-based regulation training involves using a mindfulness strategy that instructs participants to notice and accept their feelings without judgment or intent to act upon them.
Study NCT04728581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Quetiapine
Description: Use of 3.125mg quetiapine before lights-out during first 2 weeks after TKA surgery. With insufficient effect on sleep, patients are allowed to increase medication to 6.25mg mirtazapine.
Study NCT04728581 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: a gelatinous capsule without an active ingredient
Study NCT04905173 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Squat-to-stand maneuver
Description: Subjects will squat for 5 seconds and then stand. The squat-to-stand exercise will be done up to 10 times, and then immediately undergo echocardiographic imaging.
Study NCT04905173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amyl nitrite inhalation
Description: Subjects will inhale amyl nitrite prior to undergoing echocardiographic imaging. This is administered according to current laboratory protocol and is part of standard of care. This is an FDA-regulated drug that will be used as a control and will not be studied experimentally.
Study NCT04905173 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Valsalva
Description: Subjects will undergo echocardiographic imaging while performing the Valsalva maneuver. This is according to current laboratory protocol and is part of standard of care.
Study NCT06220422 — intervention group
Intervention type: PROCEDURE
Intervention: Standard Department procedure for managing direct-acting oral anticoagulants
Description: Standard Department procedure for managing direct-acting oral anticoagulants (NACO \< 50 ng/mL) in the management of fractures before September 2021
Study NCT06220422 — intervention group
Intervention type: PROCEDURE
Intervention: New Department procedure for managing direct-acting oral anticoagulants
Description: New Department procedure for managing direct-acting oral anticoagulants (NACO \< 100 ng/mL) in the management of fractures after September 2021
Study NCT05673044 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: modified Studer ileal neobladder
Description: orthotopic ileal neobladders
Study NCT05294172 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KL-A167
Description: KL-A167 4-6 cycles for combined therapy.KL-A167 maintenance.
Study NCT05294172 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: 4-6 cycles for combined therapy
Study NCT05294172 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Gemcitabine
Description: 4-6 cycles for combined therapy
Study NCT05294172 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 4-6 cycles for combined therapy.
Study NCT05294172 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cisplatin
Description: 4-6 cycles for combined therapy.
Study NCT05294172 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 4-6 cycles for combined therapy.Placebo maintenance.
Study NCT06305195 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: heart rate variability test
Description: First, the patient is required to lie on their back to have a 5-minute continuous ECG recorded, without performing any maneuvers.~Following this, deep breath test, Valsalva and stand test are performed.
Study NCT04695925 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osimertinib 80 MG [Tagrisso]
Description: osimertinib 80 mg po qd until disease progression
Study NCT04695925 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Osimertinib 80 MG [Tagrisso]
Description: osimertinib 80 mg po qd until disease progression
Study NCT04695925 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 MG Injection
Description: pemetrexed 500 mg/m2 intravenously every 3 weeks until disease progression
Study NCT04695925 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: carboplatin area under curve 5 intravenously every 3 weeks for four cycles
Study NCT06456060 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alvogyl
Description: Alvogyl soaked in a sterile gauze will be applied to cover the socket.
Study NCT06456060 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Honey
Description: Honey soaked in a sterile gauze will be applied to cover the socket.
Study NCT05819554 — intervention group
Intervention type: PROCEDURE
Intervention: Trans-sphenoidal surgery
Description: Surgical removal of pituitary tumor by trans-sphenoidal approach
Study NCT05878587 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: thermotherapy+ TENS+ low intensity high repetition exercises and Buerger Allen
Description: Patient will be asked to lie down flat on the plinth with legs elevated from 45 degrees until the skin turns pale, it will take approximately 2 minutes to occur. Then the patient turns to sit at the edge of the plinth with feet hanging and doing the following exercises; dorsiflexion, plantar flexion, inversion, eversion, and flexion the extension of toes, this phase may also be maintained for 2 minutes. Finally, the patient lies flat with his leg rested in a horizontal position and covered with a warm blanket for about 5 minutes
Study NCT05878587 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: thermotherapy+ TENS+ low intensity high repetition exercises
Description: The intervention will be repeated 3 times per day and the posttest will be conducted 5th day using KOOS, NPRS and goniometer.
Study NCT05097300 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Suboccipital inhibition
Description: The therapist will place his hands under the patient's head, making contact with the suboccipital muscles in the region of the posterior arch of the atlas, applying progressive and deep pressure. This pressure will be maintained for 10 minutes
Study NCT05097300 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Suboccipital inhibition
Description: The therapist will place his hands under the patient's head, making contact with the suboccipital muscles in the region of the posterior arch of the atlas, applying progressive and deep pressure. This pressure will be maintained for 10 minutes
Study NCT05097300 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ischemic pressure
Description: Pressures will be made on the temporal, superior trapezius, masseter and sternocleidomastoid muscles. Physical therapist will apply gradual sustained finger pressure to the muscle's active trigger points for 5-15 seconds. The therapist will begin with light firm pressure and gradually increase the pressure until the patient feels a moderate but bearable level of pain (corresponding to a level 7 on a pain scale of 1 to 10 levels where 1 indicates no pain and 10 is excruciating pain). Pressure will remain at this level until pain levels decrease to level 3. The therapist will repeat this procedure approximately 3-4 times over a 90 second period.
Study NCT05097300 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ischemic pressure
Description: Pressures will be made on the temporal, superior trapezius, masseter and sternocleidomastoid muscles. Physical therapist will apply gradual sustained finger pressure to the muscle's active trigger points for 5-15 seconds. The therapist will begin with light firm pressure and gradually increase the pressure until the patient feels a moderate but bearable level of pain (corresponding to a level 7 on a pain scale of 1 to 10 levels where 1 indicates no pain and 10 is excruciating pain). Pressure will remain at this level until pain levels decrease to level 3. The therapist will repeat this procedure approximately 3-4 times over a 90 second period.
Study NCT05097300 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Passive stretching
Description: Passive stretches will be applied to each muscle 2 times for 30 seconds, they will be performed slowly at the rate of the patient's normal breathing and checking that no compensations appear.
Study NCT05097300 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Passive stretching
Description: Passive stretches will be applied to each muscle 2 times for 30 seconds, they will be performed slowly at the rate of the patient's normal breathing and checking that no compensations appear.
Study NCT05097300 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing exercice
Description: To perform diaphragmatic breaths, there will first be an education on how to do them. The patient will lie supine, with the hips and knees semi-flexed. The therapist will ask you to place one hand on your chest and one on your abdomen. Successively, it will ask you to take a few deep breaths, inhaling through your nose for 2 seconds and exhaling through your mouth, with your lips pursed (almost closed) for 4 seconds, helping you to maintain the rhythm of your breath by counting out loud. The patient should note that during inspiration his hand on top of the chest does not rise (the chest remains still) and during expiration that his hand on top of the abdomen goes down (the abdomen sinks).
Study NCT06258486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ICG injection
Description: Patient will have a green dye (ICG) injected into the lymph node to better visualize non-sealed leaks in order to pre-emptively seal any lymphatic leaks.
Study NCT06258486 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Non-Injection/Control
Description: No ICG injection
Study NCT06258486 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prostatectomy with pelvic lymph node dissection
Description: Robotic assisted prostatectomy with pelvic lymph node dissection
Study NCT06258486 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Prostatectomy with pelvic lymph node dissection
Description: Robotic assisted prostatectomy with pelvic lymph node dissection
Study NCT06222320 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Description: Kinesiotaping will be applied to patients in this group in addition to painkillers. Kinesiotaping is a physical therapy technique used to treat muscle pain. It is performed with kinesiotaping tapes attached to the skin. These bands are removed after 4-5 days.
Study NCT06222320 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Painkillers
Description: Patients in this group will be treated with painkillers consisting of paracetamol and dexketoprofen.
Study NCT05890534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pycnogenol®
Description: Single center, quadruple blind randomized controlled trial comparing Pycnogenol® versus Placebo.
Study NCT05890534 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single center, quadruple blind randomized controlled trial comparing Pycnogenol® versus Placebo.
Study NCT06297733 — intervention group
Intervention type: OTHER
Intervention: Translating the Questionnaire into Turkish and Related Processes
Description: The first step is the translation from the original language to the other language. The ideal target in the translation phase is to use people who are familiar with the structure of the original language and who are familiar with the language. Two forward translation and one reverse translation methods will be applied after obtaining the written permission of the authors. After the completion of this phase, the terminological differences arising from the translators in the translation process from the original language to Turkish will be collected and discussed on the questions. The cultural adaptation study will be terminated by determining the equivalence between the Turkish version of the inventory and the English original. The final version of the questionnaire and the necessary changes will be arranged specific to the investigator's society and the authors of the original questionnaire will be consulted and the questionnaire will be finalized.
Study NCT06297733 — intervention group
Intervention type: OTHER
Intervention: Validity
Description: The inventory will be applied by face-to-face technique and convergent validity will be evaluated. Construct validity will be evaluated through exploratory and confirmatory factor analysis. Coefficients of fit will be calculated.
Study NCT06297733 — intervention group
Intervention type: OTHER
Intervention: Reliability
Description: The reliability of the items will be tested with Cronbach alpha. Test-retest reliability will be measured by ICC.
Study NCT05052112 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: E-PR-01
Description: Active arm
Study NCT05052112 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: E-PR-01
Description: Active arm
Study NCT05052112 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: E- PR-02
Description: Placebo arm
Study NCT05052112 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: E- PR-02
Description: Placebo arm
Study NCT06083324 — intervention group
Intervention type: OTHER
Intervention: Dose escalated resistance training
Description: All individuals will be engaging in resistance training during and/or after their cancer treatment
Study NCT04672525 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rifabutin
Description: 2 tablets of 150 mg per day rifabutin tablet daily for 12 weeks in 1 administration with a companion treatment
Study NCT04672525 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rifampicin
Description: 10 mg/kg per day (range 600 mg to 1,200 mg) rifampicin tablet in 1 daily dose for 12 weeks with a companion treatment
Study NCT05610306 — intervention group
Intervention type: OTHER
Intervention: Qualitative interview
Description: Qualitative interviews to gain insight into the impact of ichthyosis on the biological, psychological, and social quality of life in adult and elderly patients.
Study NCT06053957 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: early mobilization
Description: early mobilization program
Study NCT03361189 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Closed loop stimulation
Description: Closed loop stimulation is a physiologic, rate-adaptive pacing algorithm.
Study NCT03361189 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Closed loop stimulation
Description: Closed loop stimulation is a physiologic, rate-adaptive pacing algorithm.
Study NCT03361189 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard rate response
Description: Standard rate response is an algorithm to increase heartrate based on movement
Study NCT03361189 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Standard rate response
Description: Standard rate response is an algorithm to increase heartrate based on movement
Study NCT05799001 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Dance therapy
Description: Patients will be randomized in 2 groups, experimental or control.~The experimental group will have 4 months of dance therapy with a professional dancer and will then resume there usual activities.~The control group will start with their usual activities in the nursing home for the first 4 months and then, they will have dance sessions with a nurse previously trained by the dancer.
Study NCT05799001 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Dance therapy
Description: Patients will be randomized in 2 groups, experimental or control.~The experimental group will have 4 months of dance therapy with a professional dancer and will then resume there usual activities.~The control group will start with their usual activities in the nursing home for the first 4 months and then, they will have dance sessions with a nurse previously trained by the dancer.